Vicore Pharma Holding AB (VICO) Company Profile

Vicore Pharma Holding AB Company Snapshot

Vicore Pharma Holding AB operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vicore Pharma Holding AB with three other pharmaceutical manufacturers in Europe: N4 Pharma PLC of the United Kingdom (2017 sales of £109,913.00 [US$145,003.82 ] ), Enorama Pharma AB (1.57 million Swedish Kronor [US$176,635.55 ] ), and Bone Therapeutics SA which is based in Belgium (41,000.00 Euro [US$47,453.81 ] ).

Sales Analysis. During the year ended December of 2017, sales at Vicore Pharma Holding AB were SEK 932,000.00 (US$104.66 thousand). This is an increase of 9.4% versus 2016, when the company's sales were SEK 852,000.00 .

Vicore Pharma Holding AB

Stock Data:

Recent Stock Performance:

Current Price (10/12/2018): 19.35
(Figures in Swedish Kronor)

1 Week	-7.4%	13 Weeks	11.5%

4 Weeks	56.1%	52 Weeks	-16.4%

Vicore Pharma Holding AB Key Data:

Ticker:	VICO	Country:	Sweden

Exchanges:	STO	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2017 Sales	932,000 (Year Ending Jan 2018).	Employees:	N/A

Currency:	Swedish Kronor	Market Cap:	350,414,833

Fiscal Yr Ends:	December	Shares Outstanding:	18,109,294

Share Type:	Aktie	Closely Held Shares:

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.